多重特異性分子及びその使用 - Marengo Therapeutics, Incorporated

Title:

多重特異性分子及びその使用

Document Type and Number:

Japanese Patent JP7348899

Kind Code:

B2

Abstract:

Multispecific molecules comprising (i) a TGF-beta inhibitor and (ii) a binding moiety that binds to CSF1R or CCR2, and methods of using the same, are disclosed.

More Like This:

WO/2022/206961	ANTI-CD24 MONOCLONAL ANTIBODIES AND USES THEREOF
JP7433222	ALK7 binding protein and its use
WO/2022/151959	CAR-T CELL TARGETING B7-H3 AND APPLICATION THEREOF IN TREATMENT OF ACUTE MYELOID LEUKEMIA

Inventors:

Rowe, Andreas
Vash, Brian Edward
Maiocco, Stephanie Jay.

Application Number:

JP2020531045A

Publication Date:

September 21, 2023

Filing Date:

December 07, 2018

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Marengo Therapeutics, Incorporated

International Classes:

C12N15/13; A61K38/17; A61K39/395; A61K45/00; A61P35/00; A61P35/02; A61P35/04; A61P43/00; C07K14/495; C07K16/28; C07K16/46; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/62; C12P21/08

Domestic Patent References:

JP2013521311A
JP2017506217A
JP2016531150A
JP2017533912A

Foreign References:

WO2017091429A1
WO2016173605A1
US20170275353
WO2017165464A1

Other References:

Adv Drug Deliv Rev., 2017, 114:206-221

Attorney, Agent or Firm:

Osamu Yamamoto
Toru Miyamae
Junichi Matsuo
Takumi Terachi

Previous Patent: Photocleavable nucleotide reagent with high stability

Next Patent: System and method for producing predetermined structures from bulk diamond